Clinical Trial: A Study to Assess the Safety and Tolerability, and Pharmacokinetics of UCB0022 in Healthy Caucasian, Japanese, and Chinese Participants

U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT06970301) titled 'A Study to Assess the Safety and Tolerability, and Pharmacokinetics of UCB0022 in Healthy Caucasian, Japanese, and Chinese Participants' on May 12.

Brief Summary: The primary purpose of this study is to assess the safety and tolerability of oral glovadalen (UCB0022) in healthy Caucasian, Japanese, and Chinese participants.

Study Start Date: April 28

Study Type: INTERVENTIONAL

Condition: Healthy Study Participants

Intervention: DRUG: glovadalen

Study participants will receive doses of glovadalen (UCB0022) at pre-specified time points during the Treatment Period of Part A and Part B.

OTHER: Placebo

Study participants will rece...